Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

8.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.890
Bid (Size) 8.330 (1)
Ask (Size) 8.890 (1)
Prev. Close 8.890
Today's Range 8.890 - 8.890
52wk Range 4.720 - 22.50
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
+2.42%
+2.42%
1 Month
-49.05%
-49.05%
3 Month
-17.76%
-17.76%
6 Month
-11.50%
-11.50%
1 Year
+64.02%
+64.02%

More News

Read More
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Crude Oil Up 2%; Siyata Mobile Shares Jump
Via Benzinga
Exposures Fossil Fuels
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
Via Benzinga
What 4 Analyst Ratings Have To Say About IGM Biosciences
Via Benzinga
In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
Via Benzinga
Dow Dips Over 300 Points; Viad Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Government
Exposures Political
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
Via Benzinga
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
From IGM Biosciences, Inc.
Via GlobeNewswire
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
From IGM Biosciences, Inc.
Via GlobeNewswire
IGMS Stock Earnings: IGM Biosciences Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
Via Benzinga
Topics Economy
Exposures Interest Rates
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
IGM Biosciences to Present at the Jefferies Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.